Johnson & Johnson Balance Sheet
NYSE: JNJHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Johnson & Johnson financial position
At the end of fiscal 2025, Johnson & Johnson reported total assets of $199.21 billion, up 10.6% from a year earlier against total liabilities of $117.67 billion. Shareholders' equity stood at $81.54 billion, or 40.9% of assets. The company held $19.71 billion in cash and equivalents against $47.94 billion of debt, a net debt position of $28.23 billion.
The current ratio (current assets divided by current liabilities) was 1.03, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.59.
Summary generated from market data by MetaCap's automated system. Methodology
Johnson & Johnson balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-28 | FY 20242024-12-29 | FY 20232023-12-31 | FY 20222023-01-01 | FY 20212022-01-02 | FY 20202021-01-03 | FY 20192019-12-29 | FY 20182018-12-30 | FY 20172017-12-31 | FY 20162017-01-01 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 19.71B | 24.11B | 21.86B | 12.89B | 14.49B | 13.98B | 17.30B | 18.11B | 17.82B | 18.97B |
| Short-Term Investments | 393.00M | 417.00M | 1.07B | 9.39B | 17.12B | 11.20B | 1.98B | 1.58B | 472.00M | 22.93B |
| Receivables | 17.18B | 14.84B | 14.87B | 14.04B | 15.28B | 13.58B | 14.48B | 14.10B | 13.49B | 11.70B |
| Inventory | 14.19B | 12.44B | 11.18B | 10.27B | 10.39B | 9.34B | 9.02B | 8.60B | 8.77B | 8.14B |
| Total Current Assets | 55.62B | 55.89B | 53.49B | 55.29B | 60.98B | 51.24B | 45.27B | 46.03B | 43.09B | 65.03B |
| Property, Plant & Equipment | 23.17B | 20.52B | 19.90B | 17.98B | 18.96B | 18.77B | 17.66B | 17.04B | 17.00B | 15.91B |
| Goodwill | 48.77B | 44.20B | 36.56B | 36.05B | 25.44B | 36.39B | 33.64B | 30.45B | 31.91B | 22.80B |
| Intangible Assets | 50.40B | 37.62B | 34.17B | 38.49B | 46.39B | 53.40B | 47.64B | 47.61B | 53.23B | 26.88B |
| Total Assets | 199.21B | 180.10B | 167.56B | 187.38B | 182.02B | 174.89B | 157.73B | 152.95B | 157.30B | 141.21B |
| Accounts Payable | 11.99B | 10.31B | 9.63B | 9.89B | 11.05B | 9.51B | 8.54B | 7.54B | 7.31B | 6.92B |
| Short-Term Debt | 8.50B | 6.00B | 3.50B | 12.80B | 3.80B | 2.60B | 1.20B | 2.80B | 3.90B | 4.70B |
| Total Current Liabilities | 54.13B | 50.32B | 46.28B | 55.80B | 45.23B | 42.49B | 35.96B | 31.23B | 30.54B | 26.29B |
| Long-Term Debt | 39.44B | 30.65B | 25.88B | 26.89B | 29.98B | 32.63B | 26.49B | 27.68B | 30.68B | 22.44B |
| Total Liabilities | 117.67B | 108.61B | 98.78B | 110.57B | 108.00B | 111.62B | 98.26B | 93.20B | 97.14B | 70.79B |
| Shareholders' Equity | 81.54B | 71.49B | 68.77B | 76.80B | 74.02B | 63.28B | 59.47B | 59.75B | 60.16B | 70.42B |
| Retained Earnings | 168.98B | 155.79B | 153.84B | 128.34B | 123.06B | 113.89B | 110.66B | 106.22B | 101.79B | 110.55B |
| Total Debt | 47.94B | 36.65B | 29.38B | 39.69B | 33.78B | 35.23B | 27.69B | 30.48B | 34.58B | 27.14B |
| Net Cash (Debt) | -27.84B | -12.13B | -6.45B | -17.41B | -2.18B | -10.05B | -8.41B | -10.80B | -16.28B | 14.77B |
This table shows 10 annual periods of Johnson & Johnson's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow JNJ's reporting calendar. What is a balance sheet?